1. Zuckner J. Drug-related myopathies. Rheum Dis Clin North
Am 1994; 20:1017-32.
2. Lane RJ, Mastaglia FL. Drug-induced myopathies in man.
Lancet 1978; 2:562-6.
3. Sieb JP, Gillessen T. Iatrogenic and toxic myopathies. Muscle
Nerve 2003; 27:142-56.
4. Von Kemp K, Herregodts P, Duynslaeger L. Muscular fibrosis
due to chronic intramuscular administration of narcotic
analgesics. Acta Clin Belg 1989; 44: 383-7.
5. Haller RG, Knockel JP. Skeletal muscle disease in alcoholism.
Med Clin North Am 1984; 68:91-103.
6. Gabow PA, Kaehny WD, Kelleher SP. The spectrum of
rhabdomyolysis. Medicine (Baltimore) 1982; 61:141-9.
7. Song SK, Rubin E. Ethanol produces muscle damage in human
volunteers. Science 1972; 175:327-33.
8. Lafair JS, Myerson RM. Alcoholic myopathy with special
reference to the significance of creatine phosphokinase. Arch
Intern Med 1968; 122:417-21.
9. Martin F, Ward K, Slavin G. Alcoholic skeletal myopathy, a
clinical and pathological study. Q J Med 1985; 55:233-51.
10. Urbano-Marquez A, Estruch R, Fernandez-Sola J. The greater
risk of alcoholic cardiomyopathy and myopathy in women
compared with men. JAMA 1995; 274:149-54.
11. Fernandez-Sola J, Estruch R, Grau JM. The relation of
alcoholic myopathy to cardiomyopathy. Ann Intern Med 1994;
120:529-36.
12. Urbano-Marquez A, Estruch R, Navarro-Lopez F. The effects
of alcoholism on skeletal and cardiac muscle. N Engl J Med
1989; 320: 409-15.
13. Pogue VA, Nurse HM. Cocaine-associated acute myoglobinuric
renal failure. Am J Med 1989; 86:183-6.
14. Singhal PC, Rubin RB, Peters A. Rhabdomyolysis and acute
renal failure assoicated with cocaine abuse. J Toxicol Clin
Toxicol 1990; 28:321-30.
15. Zamora-Quezada JL, Dinerman H, Stadecker MJ. Muscle and
skin infarction after free-basing cocaine (crack). Ann Intern
Med 1988; 19:1137-43.
16. Parks JM, Knochel JP. Case report: Cocaine-associated
rhabdomyolysis. Am J Med Sci 1989; 297:334-6. İlaca Bağlı Miyopatiler
133
17. Roth D, Alarcon FJ, Fernandez JA. Acute rhabdomyolysis
associated with cocaine intoxication. N Engl J Med 1988;
319:673-7.
18. Brody SL, Wrenn KD, Wilber MM, Slovis CM. Predicting the
severity of cocaine-associated rhabdomyolysis. Ann Emerg
Med 1990; 19:1137-43.
19. Hansen KE, Hildebrand JP, Ferguson EE, Stein JH. Outcomes
in 45 patients with statin-associated myopathy. Arch Intern
Med 2005; 165:2671-6.
20. Ballantyne CM, Corsini A, Davidson MH. Risk for myopathy
with statin therapy in high-risk patients. Arch Intern Med 2003;
163:553-64.
21. Graham DJ, Staffa JA, Shatin D. Incidence of hospitalized
rhabdomyolysis in patients treated with lipid-lowering drugs.
JAMA 2004; 292:2585-90.
22. Staffa JA, Changa J, Green L. Cerivastatin and reports of fatal
rhabdomyolysis. N Engl J Med 2002; 346:539-43.
23. Ghirlanda G, Oradei A, Manto A. Evidence of plasma CoQ10-
lowering effect by HMG-CoA reductase inhibitors: a doubleblind, placebo-controlled study. J Clin Pharmacol 1993;
33:226-9.
24. Lamperti C, Naini AB, Lucchini V. Muscle CoQ10 level in
statin-related myopathy. Arch Neurol 2005; 62:1709-12.
25. Al-Jubori MA, Briston PG, Sinclair D. Myxoedema revealed by
simvastatin induced myopathy. BMJ 1994; 308:588-601.
26. Kelly P, Vasu S, Gelota M. CoQ10 improves myopathic pain in
statin treated patients. J Am Coll Cardiol 2005; 45(3): 1-7.
27. Koumis T, Nathan JP, Rosenberg JM, Cicero LA. Strategies for
the prevention and treatment of statin-induced myopathy: is
there a role for CoQ10 supplementation? Am J Health Syst
Pharm 2004; 61: 515-9.
28. Litin SC, Anderson CF. Nicotinic acid-associated myopathy: A
report of three cases. Am J Med 1989; 86:481-3.
29. Magarian GJ, Lucas LM, Colley C. Gemfibrozil-induced
myopathy. Arch Intern Med 1991; 151:1873-4.
30. Affi AK, Bergman RA, Harvey JC. Steroid myopathy. Clinical,
histologic and cytologic observations. Johns Hopkins Med J
1968; 123:158-64.
31. Bowyer SL, LaMothe MP, Hollister JR. Steroid myopathy:
Incidence and detection in a population with asthma. J Allergy
Clin Immunol 1985; 76:234-42.
32. Herzog AG. Proximal myopathy associated with inhaled
steroids. JAMA 1999; 281:37-45.
33. Braunstein PW, DeGirolami U. Experimental corticosteroid
myopathy. Acta Neuropathol 1981; 55:167-72.
34. Kelly FJ, McGrath JA, Goldspink DF, Cullen MJ. A
morphological / biochemical study on the actions of
corticosteroids on rat skeletal muscle. Muscle Nerve 1986; 9:1-
10.
35. Singleton JR, Baker BL, Thorburn A. Dexamethasone inhibits
insulin-like growth factor signalling and potentiates myoblast
apoptosis. Endocrinology 2000; 141:2945-50.
36. Stitt TN, Drujan D, Clarke BA. The IGF-1/ P13K/ Akt pathway
prevents expression of muscle atrophy-induced ubiquitin
ligases by inhibiting FOXO transcription factors. Mol Cell
2004; 14:395-403.
37. Price SR. Increased transcription of ubiquitin-proteasome
system components: molecular responses associated with
muscle atrophy. Int J Biochem Cell Biol 2003; 35:617-28.
38. Khaleeli AA, Edwards RH, Gohil K. Corticosteroid myopathy:
a clinical and pathological study. Clin Endocrinol 1983;
18:155-66.
39. Dropcho EJ, Soong SJ. Steroid-induced weakness in patients
with primary brain tumors. Neurology 1991; 41:1235-9.
40. Uri DS, Biavis M. Colchicine neuromyopathy. Clinical,
electromyographic, magnetic resonance, and histologic features.
J Clin Rheumatol 1996; 2:163-9.
41. Kuncl RW, Duncan G, Watson D. Colchicine myopathy and
neuropathy. N Engl J Med 1987; 316:1562-8.
42. Wallace SL, Singer JZ, Duncan GJ. Renal function predicts
colchicine toxicity: Guidelines for prophylactic use of
colchicine in gout. J Rheumatol 1991; 18:264-9.
43. Avina-Zubieta JA, Johnson ES, Suarez-Almazor ME, Russell
AS. Incidence of myopathy in patients treated with
antimalarials. A report of three cases and a review of the
literature. Br J Rheumatol 1995; 34:166-70.
44. Wittes R. Neuromyopathy associated with amodiaquine
hydrochloride. CMAJ 1987; 137:635-6.
45. Estes ML, Ewing-Wilson D, Chou SM. Chloroquine
neuromyotoxicity. Clinical and pathologic perspective. Am J
med 1987; 82:447-55.
46. Iglesias Cubero G, Rodriguez Reguero J, Rojo Ortega JM.
Restrictive cardiomyopathy caused by chloroquine. Br Heart J
1993; 69:451-2.
47. Ratliff NB, Estes ML, Myles JL. Diagnosis of chloroquine
cardiomyopathy by endomyocardial biopsy. N Engl Med 1987;
316:191-8.
48. Halla JT, Fallahi S, Koopman WJ. Penicillamine-induced
myositis. Observations and unique features in two patients and
review of the literature. Am J Med 1984; 77:719-22.
49. Carroll GJ, Will RK, Peter JB. Penicillamine induced
polymyositis and dermatomyositis. J Rheumatol 1987; 14:995-
1001.
Thank you for copying data from http://www.arastirmax.com